Search clinical trials for: Rifaximin (Sandoz GmbH) tablet

Total 75 results

Sandoz

Terminated

A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

Travelers' Diarrhea

Mexico
Bausch Health Americas, Inc.

Completed

Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis

Liver Cirrhosis

United States, Russian Federation
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

Healthy
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions

Healthy
National University Hospital, Singapore
National University, Singapore

Completed

Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome With Diarrhea

Singapore
Alfasigma S.p.A.
Parexel

Terminated

Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis (VARIANT)

BACTERIAL VAGINOSIS

United States
Alfasigma S.p.A.

Terminated

Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications. (ROAD)

Diverticulitis

France, Germany, Italy, Netherlands, Spain, United Kingdom
Yokohama City University
ASKA Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

Chronic Intestinal Pseudo-obstruction

Japan
Alfasigma S.p.A.

Unknown

Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test

Papulopustular Rosacea

Italy
University of North Carolina, Chapel Hill
Bausch Health Americas, Inc.

Not yet recruiting

Rifaximin for the Secondary Prevention of Recurrent Pouchitis

Pouchitis

United States
Alfasigma S.p.A.
Cromsource

Terminated

A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention (STOP-PER)

Crohn Disease

Italy
David E. Kaplan, MD MSc
Bausch Health Americas, Inc.

Terminated

Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis

Liver Cirrhosis | Chronic Hepatitis C

United States
Bausch Health Americas, Inc.
Salix Pharmaceuticals, Inc. a division of Bausch Health US, LLC

Terminated

One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease

Crohn's Disease

United States
Wake Forest University Health Sciences
University of Minnesota; Nationwide Children's Hospital; University of Texas...

Not yet recruiting

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis

Abdominal Pain | Cystic Fibrosis | Small Bowel Disease

United States
Taipei Medical University Shuang Ho Hospital

Unknown

Modulation of Gut Microbiota by Rifaximin in PD Patients

Inflammation | Parkinson Disease

Taiwan
King's College Hospital NHS Trust
King's College London

Completed

Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy (RIFSYS)

Liver Cirrhosis | Hepatoencephalopathy, Early Fatal Progressive

United Kingdom
Sadat City University

Recruiting

Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

Irritable Bowel Syndrome With Diarrhea

Egypt
University of Michigan
Food and Drug Administration (FDA)

Recruiting

Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

Human Gastrointestinal Physiology Data

United States
Samar Atef Sebaweh Mohammed

Completed

Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients

Ascites Infection

Egypt
Bodil Lund

Completed

Antibiotic Prophylaxis - Amoxicillin

Healthy

Sweden
Academisch Medisch Centrum - Universiteit van Amsterdam...
Radboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; University... and other collaborators

Recruiting

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose (PEARL)

Liver Diseases | Hepatic Encephalopathy | Portal Hypertension | Cirrhosis, Liver | Pathological Processes

Netherlands, Belgium
Cedars-Sinai Medical Center
University of Chicago; Bausch Health Americas, Inc.

Completed

Rifaximin for the Treatment of Irritable Bowel Syndrome

Irritable Bowel Syndrome
Catholic University of the Sacred Heart

Completed

Immunohistology in USDD and Correlation Between Bacterial Flora and Phlogosis

Diverticular Disease

Italy
North-West University, South Africa
Medical Research Council, South Africa; Swiss Federal Institute of Technology; Unilever R...

Completed

The Effects of Iron and Omega-3 Fatty Acid Supplementation on Cognition and Immune Function in Iron Deficient Children (FeFA)

Anemia | Iron Deficiency

South Africa
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

Seizure
New Mexico State University
University of Texas; Paso del Norte Health Foundation; Brigham Young University; Ysleta Independent School District, El Paso

Completed

Using Reinforcement Schedules to Increase Fruit&Vegetable Intake, Reduce Waste, and Increase School Lunch Participation

Psychology, Social | Nutrition | Behavioral Changes

United States
NYU Langone Health
Bausch Health Americas, Inc.

Terminated

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.

Hepatic Encephalopathy

United States
University of Geneva, Switzerland
University of Lausanne

Recruiting

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies (AMA)

Periodontal Diseases | Pharmacokinetics | Antibiotics

Switzerland
AB Biotics, SA

Terminated

Effect of a Probiotic Formula on Reducing SIBO in IBS Patients

Irritable Bowel Syndrome | Small Intestinal Bacterial Overgrowth

Spain
Mayo Clinic

Completed

Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth

Parkinson's Disease

United States
Oslo University Hospital

Completed

The Rifaximin Study in CVID

Common Variable Immunodeficiency (CVID)

Norway
Actavis Inc.

Completed

Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea

Diarrhea

United States
Aristotle University Of Thessaloniki
Hellenic Society of Hypertension

Completed

The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure

Hypertension | Diabetes | Insulin Resistance

Greece
Bausch Health Americas, Inc.

Completed

Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy

Hepatic Encephalopathy

United States, Canada
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

Healthy
Sandoz

Completed

A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions

Type 2 Diabetes
Bausch Health Americas, Inc.

Terminated

Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Bezmialem Vakif University

Completed

Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients

Fatty Liver | Steatohepatitis

Turkey
Bezmialem Vakif University

Completed

The Effects of Rifaximin Therapy in Irritable Bowel Syndrome

IBS

Turkey
Sandoz

Completed

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

Allergy
Columbia University

Unknown

Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant (Rifaximin)

Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...

Completed

Suppression Of Bacterial Vaginosis (BV) [SUBVert]

Bacterial Vaginosis

United States
University Medicine Greifswald

Completed

Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects

Hypercholesterolemia | Pharmacokinetics | Immunosuppression | Drug Interactions

Germany
RenJi Hospital

Unknown

The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps

Colon Polyps | Combizym | Bifidobacteri

China
Vastra Gotaland Region
Göteborg University

Recruiting

Progesterone as Luteal Support in Frozen IVF Natural Cycles (ProFET)

Infertility | Embryo Transfer

Sweden
Second Affiliated Hospital, School of Medicine,...
Peking Union Medical College Hospital; RenJi Hospital; Sir Run Run Shaw Hospital and other collaborators

Unknown

Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D

Gut Microbiota | IBS - Irritable Bowel Syndrome

China
The Affiliated Hospital of Qingdao University

Unknown

Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition

Healthy Volunteers

China
Sandoz

Completed

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Prostate Cancer | Hirsutism
Chinese University of Hong Kong
Beijing Friendship Hospital

Recruiting

Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users

Small Bowel Disease | Rifaximin

China, Hong Kong
Sandoz

Completed

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Prostate Cancer | Hirsutism

Search clinical trials for: Rifaximin (Sandoz GmbH) tablet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations